The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid
Oct 11 (Reuters) - Merck & Co Inc (MRK.N) said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to . . .